From Crawling to Caring: The Evolution of Clinical Practice with AI and Its Transformative Impact on Healthcare

As clinicians begin to rely more on AI, they will also need to cultivate new skills, particularly around critical interpretation of AI-generated insights, to fully leverage its potential in patient care. The post From Crawling to Caring: The Evolution of Clinical Practice with AI and Its Transformative Impact on Healthcare appeared first on MedCity News.

Read More

Denali’s Data in Rare Enzyme Deficiency Keep It on Pace to Seek Speedy FDA Approval

Currently available therapies for Hunter syndrome don’t cross the blood-brain barrier to address cognitive symptoms of the inherited enzyme deficiency. Denali Therapeutics’ technology gets its drug across the protective membrane, and the biotech plans to seek accelerated FDA approval in this rare disease. The post Denali’s Data in Rare Enzyme Deficiency Keep It on Pace…

Read More

Links

Hatch Waxman turns 40. FDA: Integrating RCT into routine clinical practice.Cost of care under Medicare vs. Medicaid.The Less-Efficient Market Hypothesis.Semaglutide and COVID-19.Statistical Modeling, Causal Inference, and Social Science turns 20.

Read More

A deeper dive into drug revenue and cost

Many people don’t understand why pharmaceuticals cost so much money. Don’t pharmaceutical companies make a lot of money? The answer is ‘yes’, but only if the drugs are successful. A paper by Wouters et al. (2024) found that: Based on data for 361 of 558 new therapeutic agents approved over the study period (median follow-up…

Read More